Eleven Month Progression-Free Survival on Vemurafenib Monotherapy in a Patient With Recurrent and Metastatic
BRAF
V600E-Mutated Glioblastoma WHO Grade 4
JCO Precis Oncol
.
2017 Nov:1:1-5.
doi: 10.1200/PO.17.00055.
Authors
Kanita Beba Abadal
1
,
Meggen A Walsh
1
,
Anthony T Yachnis
1
,
David D Tran
1
,
Ashley P Ghiaseddin
1
Affiliation
1
All authors: University of Florida, Gainesville, FL.
PMID:
35172504
DOI:
10.1200/PO.17.00055
No abstract available